Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells

LuZhe Sun, Gengfei Wu, James K V Willson, Elizabeth Zborowska, Junhua Yang, Indunilka Rajkarunanayake, Jing Wang, Larry E. Gentry, Xiao Fan Wang, Michael G. Brattain

Research output: Contribution to journalArticle

304 Citations (Scopus)

Abstract

The role of transforming growth factor (TGF) β type II receptor in reversing the malignant phenotype of human breast cancer MCF-7 cells was examined. MCF-7 cells were insensitive to TGFβ1 and expressed undetectable levels of cell surface TGFβ type I receptor (RI) and type II receptor (RII) by cross-linking with 125I-TGFβ1. Stable transfection of a RII expression vector yielded 3 transfectants with varying levels of exogenous RII mRNA and protein levels. Expression of RII also increased TGFβ1 binding to RI in all 3 clones. Proliferation of RII-positive clones was inhibited by exogenous TGFβ1 in a dose-dependent manner, whereas the control clones remained TGFβ-insensitive. The RII transfectants were growth arrested in monolayer culture at saturation densities which were 41-66% of that of the Neo controls. They also showed reduced clonogenicity in soft-agarose. Tumorigenicity in ovariectomized, estrogen-supplemented nude mice was delayed in transfectants with low RII levels. Transfectants expressing high levels of RII showed a large reduction in tumorigenicity as well as a longer delay in tumor formation. Tumor growth was associated with loss of exogenous RII expression in transfectants. The results indicate that when systems for TGFβ signal transduction are intact, reconstitution of the TGFβ receptor system can lead to reversion of malignancy in cells lacking RII.

Original languageEnglish (US)
Pages (from-to)26449-26455
Number of pages7
JournalJournal of Biological Chemistry
Volume269
Issue number42
StatePublished - Oct 21 1994

Fingerprint

Growth Factor Receptors
MCF-7 Cells
Transforming Growth Factors
Breast Neoplasms
Clone Cells
Neoplasms
Tumors
Signal transduction
Growth
Nude Mice
Sepharose
Transfection
Monolayers
Signal Transduction
Estrogens
Phenotype
Messenger RNA
Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Sun, L., Wu, G., Willson, J. K. V., Zborowska, E., Yang, J., Rajkarunanayake, I., ... Brattain, M. G. (1994). Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. Journal of Biological Chemistry, 269(42), 26449-26455.

Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. / Sun, LuZhe; Wu, Gengfei; Willson, James K V; Zborowska, Elizabeth; Yang, Junhua; Rajkarunanayake, Indunilka; Wang, Jing; Gentry, Larry E.; Wang, Xiao Fan; Brattain, Michael G.

In: Journal of Biological Chemistry, Vol. 269, No. 42, 21.10.1994, p. 26449-26455.

Research output: Contribution to journalArticle

Sun, L, Wu, G, Willson, JKV, Zborowska, E, Yang, J, Rajkarunanayake, I, Wang, J, Gentry, LE, Wang, XF & Brattain, MG 1994, 'Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells', Journal of Biological Chemistry, vol. 269, no. 42, pp. 26449-26455.
Sun L, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I et al. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. Journal of Biological Chemistry. 1994 Oct 21;269(42):26449-26455.
Sun, LuZhe ; Wu, Gengfei ; Willson, James K V ; Zborowska, Elizabeth ; Yang, Junhua ; Rajkarunanayake, Indunilka ; Wang, Jing ; Gentry, Larry E. ; Wang, Xiao Fan ; Brattain, Michael G. / Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. In: Journal of Biological Chemistry. 1994 ; Vol. 269, No. 42. pp. 26449-26455.
@article{0ecc6c8f7c2f42e398f47fbaffb4a6e8,
title = "Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells",
abstract = "The role of transforming growth factor (TGF) β type II receptor in reversing the malignant phenotype of human breast cancer MCF-7 cells was examined. MCF-7 cells were insensitive to TGFβ1 and expressed undetectable levels of cell surface TGFβ type I receptor (RI) and type II receptor (RII) by cross-linking with 125I-TGFβ1. Stable transfection of a RII expression vector yielded 3 transfectants with varying levels of exogenous RII mRNA and protein levels. Expression of RII also increased TGFβ1 binding to RI in all 3 clones. Proliferation of RII-positive clones was inhibited by exogenous TGFβ1 in a dose-dependent manner, whereas the control clones remained TGFβ-insensitive. The RII transfectants were growth arrested in monolayer culture at saturation densities which were 41-66{\%} of that of the Neo controls. They also showed reduced clonogenicity in soft-agarose. Tumorigenicity in ovariectomized, estrogen-supplemented nude mice was delayed in transfectants with low RII levels. Transfectants expressing high levels of RII showed a large reduction in tumorigenicity as well as a longer delay in tumor formation. Tumor growth was associated with loss of exogenous RII expression in transfectants. The results indicate that when systems for TGFβ signal transduction are intact, reconstitution of the TGFβ receptor system can lead to reversion of malignancy in cells lacking RII.",
author = "LuZhe Sun and Gengfei Wu and Willson, {James K V} and Elizabeth Zborowska and Junhua Yang and Indunilka Rajkarunanayake and Jing Wang and Gentry, {Larry E.} and Wang, {Xiao Fan} and Brattain, {Michael G.}",
year = "1994",
month = "10",
day = "21",
language = "English (US)",
volume = "269",
pages = "26449--26455",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "42",

}

TY - JOUR

T1 - Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells

AU - Sun, LuZhe

AU - Wu, Gengfei

AU - Willson, James K V

AU - Zborowska, Elizabeth

AU - Yang, Junhua

AU - Rajkarunanayake, Indunilka

AU - Wang, Jing

AU - Gentry, Larry E.

AU - Wang, Xiao Fan

AU - Brattain, Michael G.

PY - 1994/10/21

Y1 - 1994/10/21

N2 - The role of transforming growth factor (TGF) β type II receptor in reversing the malignant phenotype of human breast cancer MCF-7 cells was examined. MCF-7 cells were insensitive to TGFβ1 and expressed undetectable levels of cell surface TGFβ type I receptor (RI) and type II receptor (RII) by cross-linking with 125I-TGFβ1. Stable transfection of a RII expression vector yielded 3 transfectants with varying levels of exogenous RII mRNA and protein levels. Expression of RII also increased TGFβ1 binding to RI in all 3 clones. Proliferation of RII-positive clones was inhibited by exogenous TGFβ1 in a dose-dependent manner, whereas the control clones remained TGFβ-insensitive. The RII transfectants were growth arrested in monolayer culture at saturation densities which were 41-66% of that of the Neo controls. They also showed reduced clonogenicity in soft-agarose. Tumorigenicity in ovariectomized, estrogen-supplemented nude mice was delayed in transfectants with low RII levels. Transfectants expressing high levels of RII showed a large reduction in tumorigenicity as well as a longer delay in tumor formation. Tumor growth was associated with loss of exogenous RII expression in transfectants. The results indicate that when systems for TGFβ signal transduction are intact, reconstitution of the TGFβ receptor system can lead to reversion of malignancy in cells lacking RII.

AB - The role of transforming growth factor (TGF) β type II receptor in reversing the malignant phenotype of human breast cancer MCF-7 cells was examined. MCF-7 cells were insensitive to TGFβ1 and expressed undetectable levels of cell surface TGFβ type I receptor (RI) and type II receptor (RII) by cross-linking with 125I-TGFβ1. Stable transfection of a RII expression vector yielded 3 transfectants with varying levels of exogenous RII mRNA and protein levels. Expression of RII also increased TGFβ1 binding to RI in all 3 clones. Proliferation of RII-positive clones was inhibited by exogenous TGFβ1 in a dose-dependent manner, whereas the control clones remained TGFβ-insensitive. The RII transfectants were growth arrested in monolayer culture at saturation densities which were 41-66% of that of the Neo controls. They also showed reduced clonogenicity in soft-agarose. Tumorigenicity in ovariectomized, estrogen-supplemented nude mice was delayed in transfectants with low RII levels. Transfectants expressing high levels of RII showed a large reduction in tumorigenicity as well as a longer delay in tumor formation. Tumor growth was associated with loss of exogenous RII expression in transfectants. The results indicate that when systems for TGFβ signal transduction are intact, reconstitution of the TGFβ receptor system can lead to reversion of malignancy in cells lacking RII.

UR - http://www.scopus.com/inward/record.url?scp=0028075837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028075837&partnerID=8YFLogxK

M3 - Article

VL - 269

SP - 26449

EP - 26455

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 42

ER -